Summary population attributable fraction of dementia prevalence associated with sensory risk factors
BackgroundHearing and vision loss can be treatable sensory risk factors for dementia. Nationally-representative estimates of the proportion of dementia prevalence associated with sensory risk factors in late-life are needed for dementia prevention strategies.ObjectiveTo estimate the fraction of dementia prevalence associated with treatable sensory risk factors (hearing and vision loss) and to evaluate differences by age, race/ethnicity, income, and sex.MethodsThis was a cross-sectional analysis of Round 12 (2022) of the National Health and Aging Trends Study, a population-based study nationally representative of US Medicare beneficiaries. Among community-living adults aged ≥65 years eligible for cognitive, hearing, and vision assessments (n = 4623), the summary population attributable fraction (PAF) of dementia from at least one objectively-measured sensory risk factor was estimated.ResultsThe prevalence of at least one sensory risk factor was 66% and dementia was 9%. The PAF of dementia from at least one sensory risk factor was 57% (95% CI: 8%-61%). PAFs were larger for individuals who were aged <80 years compared to ≥80 years (59% [95% CI: 42%-74%] versus 33% [95% CI: -6%-68%), non-Hispanic White compared to Hispanic and non-Hispanic Black (63% [95% CI: 41%-80%] versus 50% [95% CI: 16%-80%] and 32% [95% CI: -1%-64%]), and had higher income versus lower income (57% [95% CI: 36%-74%] versus 47% [95% CI: 7%-81%]). PAFs were consistent by sex.ConclusionsUp to 57% of dementia prevalence in the US was associated with clinically-significant sensory risk factors. Addressing sensory impairments could play an important role in national dementia risk reduction strategies.
Authors
- Joshua R. Ehrlich (ORCID: https://orcid.org/0000-0002-0607-3564)
- Pablo Martínez-Amezcua (ORCID: https://orcid.org/0000-0002-3076-0946)
- Jennifer A. Deal (ORCID: https://orcid.org/0000-0002-6985-048X)
- Heather Elizabeth Whitson (ORCID: https://orcid.org/0000-0002-8417-4846)
- Nicholas Simon Reed (ORCID: https://orcid.org/0000-0003-0410-6067)
- Pradeep Y. Ramulu (ORCID: https://orcid.org/0000-0002-9275-0401)
- Varshini Varadaraj (ORCID: https://orcid.org/0000-0003-2060-1316)
- Bonnielin K. Swenor (ORCID: https://orcid.org/0000-0002-6044-0951)
- Jason R. Smith (ORCID: https://orcid.org/0000-0001-9764-5849)
- Emmanuel E. Garcia Morales (ORCID: https://orcid.org/0000-0003-2239-6125)
- Xi Wang (ORCID: https://orcid.org/0000-0002-5101-0183)
- Frank R. Lin
- Louay Almidani
- Wuyang Zhang (ORCID: https://orcid.org/0009-0007-8726-6520)
Institutions
- Johns Hopkins University (US)
- Duke University (US)
- University of Michigan (US)
- Johns Hopkins Medicine (US)
- Geriatric Research Education and Clinical Center (US)
- Durham VA Health Care System (US)
- New York University (US)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1177/13872877251386439
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00